Clinical Trial Update: A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intramuscular meloxicam once daily with oral meloxicam once daily in patients with osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED